High-dose peginterferon alfa-2A (40KD) induction therapy and standard ribavirin enhances early but not sustained virological responses in HCV genotype 1 patients: Final chariot study results

Roberts, S., Weltman, M., Crawford, D. H. G., Cheng, W. S. C., Sievert, W., McCaughan, G., Desmond, P., Rawlinson, W., Marks, P., Yoshihara, M., Rizkalla, B., DePamphilis, J. and Dore, G. J. (2009). High-dose peginterferon alfa-2A (40KD) induction therapy and standard ribavirin enhances early but not sustained virological responses in HCV genotype 1 patients: Final chariot study results. In: Journal of Hepatology. 44th Annual Meeting of the European Association for the Study of the Liver, Copenhagen, Denmark, (S50-S51). 22-26 April 2009.

Author Roberts, S.
Weltman, M.
Crawford, D. H. G.
Cheng, W. S. C.
Sievert, W.
McCaughan, G.
Desmond, P.
Rawlinson, W.
Marks, P.
Yoshihara, M.
Rizkalla, B.
DePamphilis, J.
Dore, G. J.
Title of paper High-dose peginterferon alfa-2A (40KD) induction therapy and standard ribavirin enhances early but not sustained virological responses in HCV genotype 1 patients: Final chariot study results
Conference name 44th Annual Meeting of the European Association for the Study of the Liver
Conference location Copenhagen, Denmark
Conference dates 22-26 April 2009
Proceedings title Journal of Hepatology   Check publisher's open access policy
Journal name Journal of Hepatology   Check publisher's open access policy
Publication Year 2009
Sub-type Published abstract
ISSN 0168-8278
Volume 50
Start page S50
End page S51
Total pages 2
Language eng
Q-Index Code EX
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Conference Paper
Collection: School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Google Scholar Search Google Scholar
Created: Wed, 09 Mar 2011, 15:50:50 EST